Private equity firm Advent has agreed to buy Dutch medical supplier and pharmacy owner Mediq for 775 million euros ($1 billion) in cash, more than 50 percent above last week’s closing price, writes Reuters. Mediq’s management and supervisory board support the deal, and shareholders owning 20.2 percent of Mediq have already accepted the offer, according to Reuters.
Reuters – Private equity firm Advent has agreed to buy Dutch medical supplier and pharmacy owner Mediq for 775 million euros in cash, more than 50 percent above last week’s closing price, the two companies said on Monday.
Mediq’s management and supervisory board support the deal, and shareholders owning 20.2 percent of Mediq have already accepted the offer, the companies said in statement.
Advent can help Mediq grow by providing financing for takeovers, the two groups said. (Reporting by Gilbert Kreijger; Editing by Greg Mahlich) (gilbert.kreijger@thomsonreuters.com; +31205045007; Reuters Messaging: gilbert.kreijger.reuters.com@reuters.net)
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.